Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of potassium hydroxypentyl benzoate for acute ischemic stroke
CTR20181494Phase 2Active
- Sponsor
- Yunnan Biovalley Pharmaceutical
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of potassium hydroxypentylbenzoate in ischemic stroke, brain infarction, sponsored by Yunnan Biovalley Pharmaceutical. Started Jun 2020; status: active.
02
Drugs
potassium hydroxypentylbenzoate
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on CTR20181494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181494.